The GARD Cohort is a longitudinal cohort established for the early detection and prediction of dementia. Through comprehensive clinical assessments and long-term follow-up studies, we continuously collect and accumulate valuable clinical and research data.
1st Screening 19,854
2nd Screening 10,677
3rd Screening 9,128
Male
Female
CN
aMCI
AD
Age
Enrollment begins after
informed consent is obtained.
Eligibility is determined through
screening and basic assessments.
Clinical and research data are collected
through detailed evaluations.
Participants are monitored through
regular follow-up assessments.
